Hepatitis C and liver transplantation.
Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in Europe, United States and Japan. Reinfection after liver transplantation is universal and chronic liver disease develops in at least 70% of patients at 3 years, with an accelerated course compared to the nontransplant setting. These facts underscore the need for a better understanding of hepatitis C infection and the various treatment modalities. This paper attempts a brief review of the scope of the disease, as well as the different treatment modalities, with special emphasis given to orthotopic liver transplantation.
Tsoulfas
G
G
Surgical Department of Transplantation, Aristotle University, Hippokratio General Hospital, Thessaloniki, Greece. tsoulfasg@msn.com
Goulis
I
I
Giakoustidis
D
D
Akriviadis
E
E
Agorastou
P
P
Imvrios
G
G
Papanikolaou
V
V